Compass Therapeutics أخبار Eulerpool

Compass Therapeutics إيولربول AFX

أخبار سهم Compass Therapeutics

يتابع Compass Therapeutics العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Compass Therapeutics.

• ٢٣ مايو ·

  Yahoo
  Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
• ١٦ مايو ·

  TipRanks
  Compass Therapeutics: A Buy Rating on Promising Pipeline and Solid Financials
• ١٤ مايو ·

  Yahoo
  Compass Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
• ١٤ مايو ·

  TipRanks
  Buy Rating Affirmed for Compass Therapeutics on Strong Financials and Promising Clinical Trials
• ١٤ مايو ·

  TipRanks
  Stifel Nicolaus Reaffirms Their Buy Rating on Compass Therapeutics (CMPX)
• ١٣ مايو ·

  Yahoo
  Compass Therapeutics Reports 2024 First Quarter Financial Results and Provides Corporate Update
• ١٣ مايو ·

  Seeking Alpha
  Compass Therapeutics GAAP EPS of -$0.08
• ١٣ مايو ·

  Thefly.com
  Compass Therapeutics sees cash runway into late 2026
• ١٣ مايو ·

  Thefly.com
  Compass Therapeutics reports Q1 EPS (8c), consensus (11c)
• ١٣ مايو ·

  InvestorPlace
  CMPX Stock Earnings: Compass Therapeutics Beats EPS for Q1 2024